Sex steroids and sex steroid‐binding globulin levels amongst middle‐aged and elderly men and women from general population

BACKGROUND AND AIMS: Availability of age‐ and sex‐specific reference values for sex steroids and sex steroid‐binding globulin (SHBG) levels allows for appropriate interpretation of research findings and their clinical applications. We report the sex‐specific distribution and reference levels of sex steroids, including total estradiol, total testosterone and (calculated) free androgen index (cFAI), SHBG and other androgens dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulphate (DHEAS) and androstenedione across age. METHODS: Using data from 3291 participants from the prospective population‐based Rotterdam Study (2006–2008), we visualised the distribution of sex steroids and SHBG levels by calculating and depicting the 5th, 25th, 50th, 75th and 95th percentiles per year and per age‐year across 5‐year age bands to provide reference value ranges in men and women. Total estradiol and SHBG were measured using automated immunoassay and androgens using liquid chromatography‐mass spectrometry (LC–MS/MS). RESULT: Mean age was 56.8 (range 45.6–79.9) years in men and 56.9 (range 45.7–79.9) years in women. Amongst men, total estradiol and SHBG showed an increasing trend from 45 years onwards. In women, total estradiol and SHBG showed a decreasing trend from 45 years until the age of 60. From 60 years onwards, SHBG showed an increasing trend. For total testosterone, a clear declining trend was observed amongst men but not women. Other androgens showed a similar decreasing trend in both sexes from 45 years onwards. DISCUSSION AND CONCLUSION: Our study underlines sex‐specific trends in sex steroids and SHBG levels with ageing. This warrants taking into account sex‐ and age‐specific reference values for sex steroids and SHBG when investigating their impact on health outcomes to prevent controversial results and allow for their appropriate clinical application.